{"AllianceGenome": "11743", "HGNC": "11743", "MIM": "601601", "_id": "7021", "_version": 1, "accession": {"genomic": ["AJ278356.1", "AL031224.1", "AL049693.16", "CH471081.1", "CP068272.2", "NC_000006.12", "NC_060930.1", "NG_008438.1", "Y09912.1"], "protein": ["AAH37225.2", "BAF83861.1", "BAG36489.1", "CAA64990.1", "CAA71047.1", "CAC01130.1", "EAX04355.1", "EAX04356.1", "EAX04357.1", "NP_003212.2", "Q92481.2", "XP_011513139.1", "XP_016866722.1", "XP_016866723.1", "XP_016866724.1", "XP_054212256.1", "XP_054212257.1", "XP_054212258.1", "XP_054212259.1"], "rna": ["AK291172.1", "AK313749.1", "AU141084.1", "BC037225.1", "BU738725.1", "NM_003221.4", "X95694.1", "XM_011514837.3", "XM_017011233.2", "XM_017011234.2", "XM_017011235.3", "XM_054356281.1", "XM_054356282.1", "XM_054356283.1", "XM_054356284.1", "XR_007059334.1", "XR_008487432.1"], "translation": [{"protein": "BAF83861.1", "rna": "AK291172.1"}, {"protein": "AAH37225.2", "rna": "BC037225.1"}, {"protein": "XP_054212257.1", "rna": "XM_054356282.1"}, {"protein": "XP_054212256.1", "rna": "XM_054356281.1"}, {"protein": "CAA64990.1", "rna": "X95694.1"}, {"protein": "BAG36489.1", "rna": "AK313749.1"}, {"protein": "XP_016866722.1", "rna": "XM_017011233.2"}, {"protein": "XP_016866723.1", "rna": "XM_017011234.2"}, {"protein": "XP_054212258.1", "rna": "XM_054356283.1"}, {"protein": "XP_054212259.1", "rna": "XM_054356284.1"}, {"protein": "XP_011513139.1", "rna": "XM_011514837.3"}, {"protein": "XP_016866724.1", "rna": "XM_017011235.3"}, {"protein": "NP_003212.2", "rna": "NM_003221.4"}]}, "alias": ["AP-2B", "AP-2beta", "AP2-B", "PDA2"], "ensembl": {"gene": "ENSG00000008196", "protein": ["ENSP00000342252", "ENSP00000377265"], "transcript": ["ENST00000344788", "ENST00000393655", "ENST00000489228"], "translation": [{"protein": "ENSP00000342252", "rna": "ENST00000344788"}, {"protein": "ENSP00000377265", "rna": "ENST00000393655"}], "type_of_gene": "protein_coding"}, "entrezgene": "7021", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 13.8152063412, "exp_mis": 201.691334708, "exp_syn": 116.928581764, "lof_z": 3.68186989827133, "mis_z": 2.95127460710089, "mu_lof": 1.01743446931e-06, "mu_mis": 1.90235280207e-05, "mu_syn": 1.09856147543e-05, "n_lof": 0.0, "n_mis": 116.0, "n_syn": 81.0, "p_li": 0.990904305042869, "p_null": 2.31691301068591e-06, "p_rec": 0.00909337804411991, "syn_z": 2.059820965058}, "bp": 1383, "cds_end": 50811105, "cds_start": 50786604, "n_exons": 7, "nonpsych": {"exp_lof": 12.3636492112, "exp_mis": 182.409680504, "exp_syn": 105.691203595, "lof_z": 3.45322854885941, "mis_z": 3.18966390093348, "mu_lof": 1.01743446931e-06, "mu_mis": 1.90235280207e-05, "mu_syn": 1.09856147543e-05, "n_lof": 0.0, "n_mis": 97.0, "n_syn": 67.0, "p_li": 0.986391006589373, "p_null": 7.58327918549362e-06, "p_rec": 0.0136014101314415, "syn_z": 2.36949776137768}, "nontcga": {"exp_lof": 12.6963005694, "exp_mis": 185.5423518, "exp_syn": 107.560609621, "lof_z": 3.51495554980841, "mis_z": 3.09216455078135, "mu_lof": 1.01743446931e-06, "mu_mis": 1.90235280207e-05, "mu_syn": 1.09856147543e-05, "n_lof": 0.0, "n_mis": 101.0, "n_syn": 74.0, "p_li": 0.986782661162606, "p_null": 5.77828218247054e-06, "p_rec": 0.0132115605552113, "syn_z": 2.04892236408623}, "transcript": "ENST00000393655.3"}, "exons": [{"cdsend": 50843392, "cdsstart": 50818891, "chr": "6", "position": [[50818870, 50818972], [50823406, 50823865], [50828618, 50828679], [50836060, 50836280], [50837974, 50838093], [50840155, 50840297], [50843091, 50847619]], "strand": 1, "transcript": "NM_003221", "txend": 50847619, "txstart": 50818870}], "exons_hg19": [{"cdsend": 50811105, "cdsstart": 50786604, "chr": "6", "position": [[50786583, 50786685], [50791119, 50791578], [50796331, 50796392], [50803773, 50803993], [50805687, 50805806], [50807868, 50808010], [50810804, 50815332]], "strand": 1, "transcript": "NM_003221", "txend": 50815332, "txstart": 50786583}], "generif": [{"pubmed": 11505339, "text": "Novel TFAP2B mutations causing Char syndrome have a dominant-negative effect and provide a genotype-phenotype correlation."}, {"pubmed": 12228234, "text": "AP2 regulates human reduced folate carrier gene expression"}, {"pubmed": 12270648, "text": "no association between a transcription factor Activating Protein 2beta (AP-2beta) gene variant and schizophrenia"}, {"pubmed": 14673213, "text": "AP-2beta intron 2 genotype is associated with low levels of anxiety-related personality traits in women."}, {"pubmed": 14673213, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15057523, "text": "No association between the AP-2beta genotype and measures of dopamine receptor density, or CSF 5-HIAA concentrations."}, {"pubmed": 15057523, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15245963, "text": "AP-2beta expression was observed in the low-stage subtypes of renal cell carcinoma, and this transcription factor may be related to early carcinogenesis."}, {"pubmed": 15569994, "text": "Expression of MMP-2 and MMP-9 in breast cancer seems to be partly related to expression of AP-2 and HER2"}, {"pubmed": 15722186, "text": "No differences are observed in AP-2 beta genotype frequencies between 176 subjects with premenstrual dysphoric disorder (PMDD) and 91 healthy controls."}, {"pubmed": 15722186, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15940393, "text": "Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus."}, {"pubmed": 15940393, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16373396, "text": "TFAP2B may contribute to the pathogenesis of type 2 diabetes through regulation of adipocytokine gene expression, and that TFAP2B may be a promising target for treatment or prevention of this disease."}, {"pubmed": 16787706, "text": "Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 16954217, "text": "AP-2beta directly inhibits adiponectin gene expression by displacing NF-YA and binding to its promoter."}, {"pubmed": 17123722, "text": "Boys and girls with the combination of presence of the short 5-HTTLPR, and homozygosity for the long AP-2beta genotype scored significantly lower on Self-Transcendence and Spiritual Acceptance."}, {"pubmed": 17123722, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 17185054, "text": "Investigators speculate on the possible role of TFAP2B gene on the duplicated segment in the three reported cases of partial trisomy."}, {"pubmed": 17525748, "text": "TFAP2B was validated as direct target gene mediating the anti-apoptotic function of PAX3/FKHR"}, {"pubmed": 17574780, "text": "L-PGDS gene expression in TE671 cells was activated by USF1 through the aE-box within intron 4 and cooperatively by AP-2beta in the promoter in a cell-type-specific manner."}, {"pubmed": 17630431, "text": "activating enhancer-binding protein-2beta (AP-2beta) as a novel transcription factor that specifically binds to and activates the hTERT promoter in human lung cancer cells."}, {"pubmed": 17728669, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18358611, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 18358611, "text": "a potential usefulness of AP-2beta polymorphisms in explaining or predicting central nervous diseases, drug effects and side effects."}, {"pubmed": 18752453, "text": "Novel TFAP2B mutation in nonsyndromic patent ductus arteriosus is reported."}, {"pubmed": 19184334, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19325541, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19325541, "text": "Reduction of TFAP2B expression could have a protective effect against future risk of complications associated with decreased insulin sensitivity and central adiposity, such as type 2 diabetes and coronary heart disease."}, {"pubmed": 19336370, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19557161, "text": "Observational study, meta-analysis, and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19557161, "text": "TFAP2B, LYPLAL1 and MSRA are associated with adiposity and fat distribution."}, {"pubmed": 19778525, "text": "The present study identifies TFAP2b as a suggestive candidate gene in alcohol dependence."}, {"pubmed": 20019683, "text": "TFAP2B seems to regulate the expression of various adipokines in vivo"}, {"pubmed": 20607706, "text": "Loss of TFAP2B is associated with retinoblastoma."}, {"pubmed": 20703240, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20724581, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21215182, "text": "A novel splice-junction in TFAP-2B gene might lead to hereditary patent ductus arteriosus in a Chinese family."}, {"pubmed": 21504541, "text": "This study supports a role of the SLC6A4, DRD4 and TFAP2B genes in the temperament, including a gene-gene interaction between SLC6A4 and TFAP2B. It also provides evidence about an effect of the TFAP2B polymorphism in TFAP2B gene transcription."}, {"pubmed": 21643846, "text": "TFAP2B mutation should be considered a risk factor for isolated PDA. However, the detailed genetic mechanism underlying nonsyndromic the PDA-causing TFAP2B mutation is yet to be elucidated."}, {"pubmed": 21674055, "text": "central obesity-associated variants in LYPLAL1, NRXN3, MSRA, and TFAP2B"}, {"pubmed": 21766608, "text": "It causes accumulation of neutral fats and causes insulin resistance through exaggerated glucose uptake independent of insulin and induces abnormal adipokine secretion, fat cell enlargement and insulin resistance."}, {"pubmed": 22199100, "text": "The findings suggest the lack of involvement of known mutations of TFAP2B with syndromic or nonsyndromic CHDs in Mysore patients"}, {"pubmed": 22952648, "text": "Under energy restriction, TFAP2B may modify the effect of dietary fat intake on weight loss and waist reduction"}, {"pubmed": 22959235, "text": "genomic GATA4 and TFAP2B missense mutations may be associated with nonfamilial congenital heart disease with diverse clinical phenotypes in patients with congenital heart disease from southern China"}, {"pubmed": 23824473, "text": "The presence of the nine-repeat variant of the TFAP-2beta intron 1 VNTR appears to protect girls with ADHD symptoms from the co-expression of symptoms of depression."}, {"pubmed": 23881096, "text": "The AP-2beta polymorphism significantly influenced cognitive performance, whereas the MAOA and COMT polymorphisms did not."}, {"pubmed": 24081236, "text": "TFAP2B rs987237 and dietary protein/carbohydrate interacted to modify weight maintenance."}, {"pubmed": 24507797, "text": "A haploinsufficiency effect of TFAP2B could be involved in familial isolated patent ductus arteriosus."}, {"pubmed": 24766673, "text": "TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling."}, {"pubmed": 26189251, "text": "The expression of TFAP-2beta mRNA in tissue of patients with endometrial carcinoma was higher than that of normal endometrium. The expression of TFAP-2beta mRNA in endometrial tissue of patients with metabolism syndrome was higher than that of lean ones."}, {"pubmed": 26598443, "text": "results suggest that TFAP2B is playing a vital role in retaining retinoic acid responsiveness and mediating noradrenergic neuronal differentiation in neuroblastoma."}, {"pubmed": 26615960, "text": "Single nucleotide polymorphisms (SNP) in angiotensin II receptor, type 1 (AGTR1), transcription factor AP-2 beta (TFAP2B), and tumor necrosis factor receptor-associated factor 1 (TRAF1) have been reported to be associated with the incidence of PDA in preterm infants."}, {"pubmed": 28277615, "text": "AP-2 beta and beta-catenin interact both in vitro through GST pull-down assays and in vivo by co-immunoprecipitation. We further identified the interaction regions to the DNA-binding domain of AP-2 beta and the 1-9 Armadillo repeats of beta-catenin."}, {"pubmed": 28381879, "text": "TFAP2B mutation is associated with tooth abnormalities."}, {"pubmed": 29035379, "text": "Data suggest that expression of TFAP2B in lobular carcinoma in situ and invasive lobular breast cancer is up-regulated as compared to control mammary gland epithelium; TFAP2B appear to be involved in regulation of cell proliferation in these slow-growing breast cancer subtypes."}, {"pubmed": 29602546, "text": "Reduced TFAP2B expression in EC was significantly associated with high grade (OR=2.2 for well, moderate vs. poor), stage (OR=2.5 for I vs. IV), histology (OR=1.8 for serous vs. endometrioid), distant metastasis (OR=2.4 for positive vs. negative) (all p-values<0.05)."}, {"pubmed": 29683802, "text": "previously, only 10 different pathogenic variants in the TFAP2B gene have been associated with the Char syndrome and patent ductus arteriosus (human gene mutation database subscription). We have thus identified the 11th mutation, namely, c.851T>C, p. Leu284Ser, which cosegregates with the phenotype."}, {"pubmed": 29972820, "text": "study demonstrates that AP-2beta promotes tumor growth and predicts poor prognosis, and may represent a potential therapeutic target for breast cancer."}, {"pubmed": 30552118, "text": "These findings suggest that TFAP2B transcriptionally regulates CEC-specific genes and therefore may be an important transcriptional regulator of corneal endothelial development and homeostasis."}, {"pubmed": 30975199, "text": "A polymorphic Alu in the flanking region of the TFAP2B and TFAP2D genes has been identified. The new insert was found in higher frequency in Europeans (0.4) and Asians (0.38) and lower frequency in Africans (0.25)."}, {"pubmed": 31113934, "text": "TFAP2B bound to the promoter of COX-2 to activate its expression, indicating that TFAP2B is a critical regulatory molecule in the COX-2 signaling pathway that promoted tumor progression in thyroid cancer."}, {"pubmed": 31182639, "text": "AP-2beta is a binding partner for DHX33 which acts as a coactivator for AP-2beta to promote the transcription of antiapoptotic Bcl-2 gene."}, {"pubmed": 31292255, "text": "Mutations in TFAP2B and previously unimplicated genes of the BMP, Wnt, and Hedgehog pathways in syndromic craniosynostosis have been reported."}, {"pubmed": 31492751, "text": "PKD knockdown in human umbilical vein endothelial cells increases binding of AP2beta to the VEGFR-2 promoter."}, {"pubmed": 32462520, "text": "Comprehensive analysis of the expression and prognosis for TFAP2 in human lung carcinoma."}, {"pubmed": 32544596, "text": "The role of reward sensitivity in obesity and its association with Transcription Factor AP-2B: A longitudinal birth cohort study."}, {"pubmed": 32856873, "text": "TFAP2B, AP-1 and JAZF1 Expression in Tissues of Papillary Thyroid Carcinoma Patients; Clinical, Pathological and Prognostic Values."}, {"pubmed": 33720400, "text": "Transcription factor AP-2beta in development, differentiation and tumorigenesis."}, {"pubmed": 34117603, "text": "Co-expression of transcription factor AP-2beta (TFAP2B) and GATA3 in human mammary epithelial cells with intense, apicobasal immunoreactivity for CK8/18."}, {"pubmed": 35864973, "text": "TRIM37 Augments AP-2gamma Transcriptional Activity and Cellular Localization via K63-linked Ubiquitination to Drive Breast Cancer Progression."}, {"pubmed": 36689838, "text": "Transcription factor activating enhancer-binding protein 2B expression correlates with invasiveness and prognosis of extramammary Paget's disease."}, {"pubmed": 37962045, "text": "Novel Circular RNA CircUBAP2 Drives Tumor Progression by Regulating the miR-143/TFAP2B Axis in Prostate Cancer."}, {"pubmed": 38237728, "text": "AP-2alpha/AP-2beta Transcription Factors Are Key Regulators of Epidermal Homeostasis."}], "genomic_pos": {"chr": "6", "end": 50847619, "ensemblgene": "ENSG00000008196", "start": 50818723, "strand": 1}, "genomic_pos_hg19": {"chr": "6", "end": 50815326, "start": 50786436, "strand": 1}, "go": {"BP": [{"evidence": "IDA", "gocategory": "BP", "id": "GO:0000122", "pubmed": 7559606, "qualifier": "involved_in", "term": "negative regulation of transcription by RNA polymerase II"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0001822", "qualifier": "involved_in", "term": "kidney development"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0006006", "pubmed": [15940393, 16373396, 19325541], "qualifier": "involved_in", "term": "glucose metabolic process"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006357", "qualifier": "involved_in", "term": "regulation of transcription by RNA polymerase II"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006366", "qualifier": "involved_in", "term": "transcription by RNA polymerase II"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0008284", "pubmed": 17525748, "qualifier": "involved_in", "term": "positive regulation of cell population proliferation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0008285", "pubmed": 20607706, "qualifier": "involved_in", "term": "negative regulation of cell population proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0009410", "qualifier": "involved_in", "term": "response to xenobiotic stimulus"}, {"evidence": "IEP", "gocategory": "BP", "id": "GO:0010842", "pubmed": 20607706, "qualifier": "involved_in", "term": "retina layer formation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0030510", "qualifier": "involved_in", "term": "regulation of BMP signaling pathway"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0035136", "qualifier": "involved_in", "term": "forelimb morphogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0035137", "qualifier": "involved_in", "term": "hindlimb morphogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0035909", "qualifier": "involved_in", "term": "aorta morphogenesis"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0042127", "qualifier": "involved_in", "term": "regulation of cell population proliferation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0043066", "pubmed": 17525748, "qualifier": "acts_upstream_of_negative_effect", "term": "negative regulation of apoptotic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0043066", "qualifier": "involved_in", "term": "negative regulation of apoptotic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0043524", "qualifier": "involved_in", "term": "negative regulation of neuron apoptotic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0043525", "pubmed": 20607706, "qualifier": "involved_in", "term": "positive regulation of neuron apoptotic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0043588", "qualifier": "involved_in", "term": "skin development"}, {"evidence": "IEP", "gocategory": "BP", "id": "GO:0045444", "pubmed": 16373396, "qualifier": "involved_in", "term": "fat cell differentiation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045595", "pubmed": 20607706, "qualifier": "involved_in", "term": "regulation of cell differentiation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045892", "pubmed": 20607706, "qualifier": "involved_in", "term": "negative regulation of DNA-templated transcription"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045893", "pubmed": 11505339, "qualifier": "involved_in", "term": "positive regulation of DNA-templated transcription"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045893", "pubmed": 16373396, "qualifier": "involved_in", "term": "positive regulation of DNA-templated transcription"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045944", "pubmed": [7555706, 12169688], "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0048485", "qualifier": "involved_in", "term": "sympathetic nervous system development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048745", "qualifier": "involved_in", "term": "smooth muscle tissue development"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0048856", "qualifier": "involved_in", "term": "anatomical structure development"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0050796", "pubmed": [15940393, 19325541], "qualifier": "involved_in", "term": "regulation of insulin secretion"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0051402", "qualifier": "involved_in", "term": "neuron apoptotic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0072017", "qualifier": "involved_in", "term": "distal tubule development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0072044", "qualifier": "involved_in", "term": "collecting duct development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0072210", "qualifier": "involved_in", "term": "metanephric nephron development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0097070", "qualifier": "involved_in", "term": "ductus arteriosus closure"}], "CC": [{"evidence": "ISA", "gocategory": "CC", "id": "GO:0000785", "qualifier": "part_of", "term": "chromatin"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005634", "qualifier": "is_active_in", "term": "nucleus"}, {"evidence": "IC", "gocategory": "CC", "id": "GO:0005634", "pubmed": 12169688, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": 20607706, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0000977", "qualifier": "enables", "term": "RNA polymerase II transcription regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0000978", "pubmed": 7555706, "qualifier": "enables", "term": "RNA polymerase II cis-regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0000981", "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "IDA", "id": "GO:0000981", "pubmed": 7555706, "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "ISA", "id": "GO:0000981", "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "IDA", "id": "GO:0000987", "pubmed": 16373396, "qualifier": "enables", "term": "cis-regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0001228", "pubmed": 7559606, "qualifier": "enables", "term": "DNA-binding transcription activator activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "ISS", "id": "GO:0001228", "qualifier": "enables", "term": "DNA-binding transcription activator activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "TAS", "id": "GO:0003677", "pubmed": 12072434, "qualifier": "enables", "term": "DNA binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0003682", "qualifier": "enables", "term": "chromatin binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003700", "pubmed": [11505339, 12169688, 16373396], "qualifier": "enables", "term": "DNA-binding transcription factor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [7555706, 11694877, 12072434, 12586840, 19115315, 32814053], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0042803", "pubmed": 11505339, "qualifier": "enables", "term": "protein homodimerization activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0043565", "pubmed": [11505339, 12169688], "qualifier": "enables", "term": "sequence-specific DNA binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0046982", "pubmed": 11505339, "qualifier": "enables", "term": "protein heterodimerization activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:1990837", "pubmed": 28473536, "qualifier": "enables", "term": "sequence-specific double-stranded DNA binding"}]}, "homologene": {"genes": [[7955, 550545], [8364, 733930], [9031, 395713], [9544, 707679], [9598, 462758], [9606, 7021], [9615, 403463], [9913, 540867], [10090, 21419], [10116, 301285]], "id": 20688}, "interpro": [{"desc": "Transcription factor AP-2", "id": "IPR004979", "short_desc": "TF_AP2"}, {"desc": "Transcription factor AP-2 beta", "id": "IPR008122", "short_desc": "TF_AP2_beta"}, {"desc": "Transcription factor AP-2, C-terminal", "id": "IPR013854", "short_desc": "TF_AP2_C"}], "ipi": ["IPI00021557", "IPI00216446"], "map_location": "6p12.3", "name": "transcription factor AP-2 beta", "other_names": ["AP2-beta", "activating enhancer binding protein 2 beta", "transcription factor AP-2-beta"], "pantherdb": {"HGNC": "11743", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "104672", "ortholog_type": "LDO", "panther_family": "PTHR10812", "taxid": 10090, "uniprot_kb": "Q61313"}, {"RGD": "1306321", "ortholog_type": "LDO", "panther_family": "PTHR10812", "taxid": 10116, "uniprot_kb": "A0A0G2KAT2"}, {"Ensembl": "ENSGALG00000016680", "ortholog_type": "LDO", "panther_family": "PTHR10812", "taxid": 9031, "uniprot_kb": "O93346"}, {"ZFIN": "ZDB-GENE-050417-394", "ortholog_type": "LDO", "panther_family": "PTHR10812", "taxid": 7955, "uniprot_kb": "A0A286Y8U3"}, {"WormBase": "WBGene00009203", "ortholog_type": "O", "panther_family": "PTHR10812", "taxid": 6239, "uniprot_kb": "Q19862"}, {"WormBase": "WBGene00009202", "ortholog_type": "O", "panther_family": "PTHR10812", "taxid": 6239, "uniprot_kb": "Q19863"}, {"WormBase": "WBGene00013383", "ortholog_type": "O", "panther_family": "PTHR10812", "taxid": 6239, "uniprot_kb": "G2HK15"}, {"WormBase": "WBGene00019424", "ortholog_type": "O", "panther_family": "PTHR10812", "taxid": 6239, "uniprot_kb": "Q09585"}, {"FlyBase": "FBgn0261953", "ortholog_type": "O", "panther_family": "PTHR10812", "taxid": 7227, "uniprot_kb": "M9PIH9"}], "uniprot_kb": "Q92481"}, "pathway": {"reactome": [{"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-212436", "name": "Generic Transcription Pathway"}, {"id": "R-HSA-212436", "name": "Generic Transcription Pathway"}, {"id": "R-HSA-2990846", "name": "SUMOylation"}, {"id": "R-HSA-3108232", "name": "SUMO E3 ligases SUMOylate target proteins"}, {"id": "R-HSA-3232118", "name": "SUMOylation of transcription factors"}, {"id": "R-HSA-392499", "name": "Metabolism of proteins"}, {"id": "R-HSA-597592", "name": "Post-translational protein modification"}, {"id": "R-HSA-73857", "name": "RNA Polymerase II Transcription"}, {"id": "R-HSA-73857", "name": "RNA Polymerase II Transcription"}, {"id": "R-HSA-74160", "name": "Gene expression (Transcription)"}, {"id": "R-HSA-74160", "name": "Gene expression (Transcription)"}, {"id": "R-HSA-8864260", "name": "Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors"}, {"id": "R-HSA-8864260", "name": "Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors"}, {"id": "R-HSA-8866904", "name": "Negative regulation of activity of TFAP2 (AP-2) family transcription factors"}, {"id": "R-HSA-8866904", "name": "Negative regulation of activity of TFAP2 (AP-2) family transcription factors"}, {"id": "R-HSA-8866907", "name": "Activation of the TFAP2 (AP-2) family of transcription factors"}, {"id": "R-HSA-8866910", "name": "TFAP2 (AP-2) family regulates transcription of growth factors and their receptors"}, {"id": "R-HSA-9758941", "name": "Gastrulation"}, {"id": "R-HSA-9758941", "name": "Gastrulation"}, {"id": "R-HSA-9834899", "name": "Specification of the neural plate border"}, {"id": "R-HSA-9834899", "name": "Specification of the neural plate border"}], "wikipathways": [{"id": "WP2064", "name": "Neural Crest Differentiation"}, {"id": "WP3527", "name": "Pre-implantation embryo"}, {"id": "WP4352", "name": "Ciliary landscape"}]}, "pdb": "8J0Q", "pfam": "PF03299", "pharmgkb": "PA36460", "pharos": {"target_id": 11063, "tdl": "Tbio"}, "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF257135", "relationship": "is"}, {"id": "GNF257136", "relationship": "is"}, {"id": "GNF257137", "relationship": "is"}, {"id": "GNF257138", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF036018", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF091602", "relationship": "is"}, {"id": "GNF091603", "relationship": "is"}, {"id": "GNF091604", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF050847", "relationship": "is"}, {"id": "GNF055610", "relationship": "is"}, {"id": "GNF060277", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF070409", "relationship": "is"}, {"id": "GNF070410", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF014466", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF235707", "relationship": "is"}, "GNF_mm-kinase_lenti-shRNA": {"id": "GNF290242", "relationship": "is"}, "GNF_mm-kinase_plasmid-shRNA": {"id": "GNF075573", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF106709", "relationship": "is"}, {"id": "GNF146355", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000006.12", "NC_060930.1", "NG_008438.1"], "protein": ["NP_003212.2", "XP_011513139.1", "XP_016866722.1", "XP_016866723.1", "XP_016866724.1", "XP_054212256.1", "XP_054212257.1", "XP_054212258.1", "XP_054212259.1"], "rna": ["NM_003221.4", "XM_011514837.3", "XM_017011233.2", "XM_017011234.2", "XM_017011235.3", "XM_054356281.1", "XM_054356282.1", "XM_054356283.1", "XM_054356284.1", "XR_007059334.1", "XR_008487432.1"], "translation": [{"protein": "XP_054212257.1", "rna": "XM_054356282.1"}, {"protein": "XP_054212256.1", "rna": "XM_054356281.1"}, {"protein": "XP_016866722.1", "rna": "XM_017011233.2"}, {"protein": "XP_016866723.1", "rna": "XM_017011234.2"}, {"protein": "XP_054212258.1", "rna": "XM_054356283.1"}, {"protein": "XP_054212259.1", "rna": "XM_054356284.1"}, {"protein": "XP_011513139.1", "rna": "XM_011514837.3"}, {"protein": "XP_016866724.1", "rna": "XM_017011235.3"}, {"protein": "NP_003212.2", "rna": "NM_003221.4"}]}, "reporter": {"HG-U133_Plus_2": ["1553394_a_at", "214451_at", "215686_x_at"], "HG-U95Av2": "39668_at", "HTA-2_0": "TC06000647.hg.1", "HuEx-1_0": "2909948", "HuGene-1_1": "8120194", "HuGene-2_1": "17009545"}, "retired": 50953, "summary": "This gene encodes a member of the AP-2 family of transcription factors. AP-2 proteins form homo- or hetero-dimers with other AP-2 family members and bind specific DNA sequences. They are thought to stimulate cell proliferation and suppress terminal differentiation of specific cell types during embryonic development. Specific AP-2 family members differ in their expression patterns and binding affinity for different promoters. This protein functions as both a transcriptional activator and repressor. Mutations in this gene result in autosomal dominant Char syndrome, suggesting that this gene functions in the differentiation of neural crest cell derivatives. [provided by RefSeq, Jul 2008].", "symbol": "TFAP2B", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1366502"}, "unigene": "Hs.33102", "uniprot": {"Swiss-Prot": "Q92481", "TrEMBL": "X6R4Y8"}, "wikipedia": {"url_stub": "TFAP2B"}}